---
document_datetime: 2024-11-13 09:29:55
document_pages: 16
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/buccolam-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: buccolam-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 9.5395404
conversion_datetime: 2025-12-19 04:40:41.851186
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## BUCCOLAM

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                          | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| II/0061              | C.I.6.a - Change(s) to therapeutic indication(s) - Addition of a new therapeutic indication or modification of an approved one | 19/09/2024                          | 21/10/2024                                  | SmPC, Labelling and PL           |           |
| IAIN/0067/G          | This was an application for a group of variations.                                                                             | 21/10/2024                          | n/a                                         |                                  |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |            |     |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0066/G | This was an application for a group of variations. B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place | 20/09/2024 | n/a |
| IB/0064/G | This was an application for a group of variations. B.I.b.2.e - Change in test procedure for AS or starting material/reagent/intermediate - Other changes to a test procedure (including replacement                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 11/09/2024 | n/a |

<div style=\"page-break-after: always\"></div>

| or addition) for the AS material/intermediate B.I.b.2.e - Change in starting material/reagent/intermediate changes to a test procedure or addition) for the AS material/intermediate B.III.2.b - Change to comply national pharmacopoeia to comply with an update of the Ph. Eur. or national Member State B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification an obsolete parameter) B.I.b.1.d - Change in and/or limits of an AS, material/intermediate/reagent significant specification   |
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

<div style=\"page-break-after: always\"></div>

|                     | B.I.b.1.d - Change in the specification parameters and/or limits of an AS, starting material/intermediate/reagent - Deletion of a non- significant specification parameter (e.g. deletion of an obsolete parameter)                                      |            |            |                                  |                                                                                                                                            |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0065           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing                   | 05/08/2024 | n/a        |                                  |                                                                                                                                            |
| IB/0063             | B.II.d.1.h - Change in the specification parameters and/or limits of the finished product - Update of the dossier to comply with the provisions of an updated general monograph of the Ph. Eur. for the finished product                                 | 21/06/2024 | 21/10/2024 | SmPC and PL                      |                                                                                                                                            |
| N/0060              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                         | 17/01/2024 | 22/05/2024 | PL                               |                                                                                                                                            |
| PSUSA/10118 /202209 | Periodic Safety Update EU Single assessment - midazolam (oromucosal solution, treatment of prolonged, acute, convulsive seizures)                                                                                                                        | 26/04/2023 | 07/07/2023 | SmPC and PL                      | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10118/202209. |
| IAIN/0059/G         | This was an application for a group of variations. A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release A.1 - Administrative change - Change in the name and/or address of the MAH | 21/06/2023 | 22/05/2024 | SmPC, Annex II, Labelling and PL |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|             | A.7 - Administrative change - Deletion of manufacturing sites                                                                                                                                                                                                                                                                                                                           |            |            |                        |                                                                                                                                                                                                                                                                         |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| N/0058      | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                        | 08/02/2023 | 07/07/2023 | PL                     |                                                                                                                                                                                                                                                                         |
| IB/0056     | C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                                                                                                                                                                                                                                                                                          | 31/10/2022 | 07/07/2023 | SmPC and PL            | To update section 4.4 of the SmPC and section 2 of the PL to align the wording for the excipient sodium with the European Commission guideline on 'Excipients in the labelling and package leaflet of medicinal products for human use' (EMA/CHMP/302620/2017 Rev. 1*). |
| IA/0055     | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                              | 12/04/2022 | n/a        |                        |                                                                                                                                                                                                                                                                         |
| IAIN/0054   | B.II.e.6.a - Change in any part of the (primary) packaging material not in contact with the finished product formulation - Change that affects the product information                                                                                                                                                                                                                  | 10/02/2022 | 13/05/2022 | SmPC, Labelling and PL |                                                                                                                                                                                                                                                                         |
| IAIN/0053/G | This was an application for a group of variations. B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging | 18/11/2021 | 13/05/2022 | Annex II and PL        |                                                                                                                                                                                                                                                                         |

<div style=\"page-break-after: always\"></div>

| IA/0052   | B.III.1.a.2 - Submission of a new/updated or deletion of Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        | 21/09/2021   | n/a        |                        |                                                                                                                                |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|------------------------|--------------------------------------------------------------------------------------------------------------------------------|
| IB/0051/G | This was an application for a group of variations. B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes B.II.e.5.a.2 - Change in pack size of the finished product - Change in the number of units (e.g. tablets, ampoules, etc.) in a pack - Change outside the range of the currently approved pack sizes | 07/07/2021   | 13/05/2022 | SmPC, Labelling and PL | The Product Information was updated to add the additional pack size of two pre-filled syringes for each of the four strengths. |
| IAIN/0050 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 | 26/05/2021   | n/a        |                        |                                                                                                                                |
| IAIN/0049 | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    | 09/04/2021   | 13/05/2022 | Annex II and PL        |                                                                                                                                |

<div style=\"page-break-after: always\"></div>

|                     | responsible for importation and/or batch release - Not including batch control/testing                                                                                                                                                     |            |            |                        |                                                                                                                                            |
|---------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|--------------------------------------------------------------------------------------------------------------------------------------------|
| T/0048              | Transfer of Marketing Authorisation                                                                                                                                                                                                        | 22/12/2020 | 25/02/2021 | SmPC, Labelling and PL |                                                                                                                                            |
| IB/0047             | C.I.11.z - Introduction of, or change(s) to, the obligations and conditions of a marketing authorisation, including the RMP - Other variation                                                                                              | 21/01/2021 | n/a        |                        |                                                                                                                                            |
| IAIN/0046           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing     | 22/10/2020 | n/a        |                        |                                                                                                                                            |
| IB/0045             | C.I.3.a - Change(s) in the SPC, Labelling or PL intended to implement the outcome of a procedure concerning PSUR or PASS or the outcome of the assessment done under A 45/46 - Implementation of wording agreed by the competent authority | 16/10/2020 | 25/02/2021 | SmPC                   |                                                                                                                                            |
| PSUSA/10118 /201909 | Periodic Safety Update EU Single assessment - midazolam (oromucosal solution, treatment of prolonged, acute, convulsive seizures)                                                                                                          | 28/05/2020 | 27/07/2020 | SmPC and PL            | Refer to Scientific conclusions and grounds recommending the variation to terms of the Marketing Authorisation(s)' for PSUSA/10118/201909. |
| IA/0044/G           | This was an application for a group of variations. B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch                                          | 22/06/2020 | n/a        |                        |                                                                                                                                            |

<div style=\"page-break-after: always\"></div>

|             | control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |            |            |                    |               |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------------|---------------|
| IAIN/0042/G | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - | 30/10/2019 | n/a        |                    | Not including |
| IB/0041/G   | This was an application for a group of variations. B.II.d.2.d - Change in test procedure for the finished product - Other changes to a test procedure (including replacement or addition) B.II.f.1.b.1 - Stability of FP - Extension of the shelf life of the finished product - As packaged for sale (supported by real time data)                                                                                                                                                                                                                                                                                                                                       | 20/10/2019 | 27/07/2020 | SmPC and Labelling |               |

<div style=\"page-break-after: always\"></div>

| IA/0039             | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                             | 03/08/2018   | n/a        |                                  |                                   |
|---------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-----------------------------------|
| N/0038              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                       | 25/07/2018   | 12/02/2019 | Labelling                        |                                   |
| IB/0037             | B.II.b.5.f - Change to in-process tests or limits applied during the manufacture of the finished product - Addition or replacement of an in-process test as a result of a safety or quality issue                                      | 24/05/2018   | n/a        |                                  |                                   |
| IAIN/0036           | B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Replacement or addition of a manufacturer responsible for importation and/or batch release - Not including batch control/testing | 02/02/2018   | 12/02/2019 | Annex II and PL                  |                                   |
| PSUSA/10118 /201609 | Periodic Safety Update EU Single assessment - midazolam (oromucosal solution, treatment of prolonged, acute, convulsive seizures)                                                                                                      | 06/04/2017   | n/a        |                                  | PRAC Recommendation - maintenance |
| R/0032              | Renewal of the marketing authorisation.                                                                                                                                                                                                | 01/04/2016   | 26/05/2016 | SmPC, Annex II, Labelling and PL |                                   |
| IA/0033             | A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release)                                       | 02/05/2016   | n/a        |                                  |                                   |

<div style=\"page-break-after: always\"></div>

| PSUSA/10118 /201509   | Periodic Safety Update EU Single assessment - midazolam (oromucosal solution, treatment of prolonged, acute, convulsive seizures)                                                                                                                        | 17/03/2016   | n/a        |                                  | PRAC Recommendation - maintenance   |
|-----------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|----------------------------------|-------------------------------------|
| IG/0603/G             | This was an application for a group of variations. A.1 - Administrative change - Change in the name and/or address of the MAH A.5.a - Administrative change - Change in the name and/or address of a manufacturer/importer responsible for batch release | 03/12/2015   | 26/05/2016 | SmPC, Annex II, Labelling and PL |                                     |
| IG/0621               | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                          | 16/10/2015   | n/a        |                                  |                                     |
| IA/0028               | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                     | 09/10/2015   | n/a        |                                  |                                     |
| IA/0027               | B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place                                                                               | 16/07/2015   | n/a        |                                  |                                     |
| PSUSA/10118 /201409   | Periodic Safety Update EU Single assessment - midazolam (oromucosal solution, treatment of prolonged, acute, convulsive seizures)                                                                                                                        | 12/03/2015   | n/a        |                                  | PRAC Recommendation - maintenance   |

<div style=\"page-break-after: always\"></div>

| IB/0025/G   | This was an application for a group of variations. A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) A.7 - Administrative change - Deletion of manufacturing sites   | 29/10/2014   | n/a   |                                   |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|-----------------------------------|
| IA/0024     | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                                                                                                                | 26/09/2014   | n/a   |                                   |
| IAIN/0023   | C.I.8.a - Introduction of or changes to a summary of Pharmacovigilance system - Changes in QPPV (including contact details) and/or changes in the PSMF location                                                                                                                                                     | 02/07/2014   | n/a   |                                   |
| PSUV/0012   | Periodic Safety Update                                                                                                                                                                                                                                                                                              | 10/04/2014   | n/a   | PRAC Recommendation - maintenance |
| IB/0020     | B.II.b.1.e - Replacement or addition of a manufacturing site for the FP - Site where any manufacturing operation(s) take place, except batch- release, batch control, primary and secondary packaging, for non-sterile medicinal products                                                                           | 28/03/2014   | n/a   |                                   |
| IB/0021/G   | This was an application for a group of variations. B.II.e.2.c - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Deletion of a non-significant specification parameter (e.g. deletion of an obsolete                                                       | 26/03/2014   | n/a   |                                   |

<div style=\"page-break-after: always\"></div>

|             | - Change in the specification parameters limits of the immediate packaging of the product - Other variation                                                                                                                                                                                                                                                                                                        |            |            |                                  | parameter) B.II.e.2.z and/or finished   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-----------------------------------------|
| IB/0019     | Update of section 6.6 of the SmPC to include information on how to administer Buccolam as already introduced in the Package Leaflet. In addition several editorial corrections including an update of the entire PI in accordance with QRD template version 9 have also been introduced. C.I.z - Changes (Safety/Efficacy) of Human and Veterinary Medicinal Products - Other variation                            | 20/03/2014 | 05/03/2015 | SmPC, Annex II, Labelling and PL |                                         |
| IA/0022     | A.7 - Administrative change - Deletion of sites                                                                                                                                                                                                                                                                                                                                                                    | 27/02/2014 | 05/03/2015 | Annex II and PL                  | manufacturing                           |
| IAIN/0018   | B.II.b.1.b - Replacement or addition of a manufacturing site for the FP - Primary packaging site                                                                                                                                                                                                                                                                                                                   | 17/02/2014 | n/a        |                                  |                                         |
| IAIN/0016/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV and/or QPPV contact details and/or back-up procedure C.I.9.b - Changes to an existing pharmacovigilance system as described in the DDPS - Change(s) in the safety database and/or major contractual arrangements for the fulfilment of PhV obligations, | 17/02/2014 | n/a        |                                  |                                         |

<div style=\"page-break-after: always\"></div>

|           | and/or change of the site undergoing PhV activities C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the PhV system   |            |            |                  |                                                                                                                                                                                                                                                                                   |
|-----------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IA/0017   | B.II.b.3.a - Change in the manufacturing process of the finished or intermediate product - Minor change in the manufacturing process                                                                                           | 12/02/2014 | n/a        |                  |                                                                                                                                                                                                                                                                                   |
| IB/0015   | B.II.e.1.z - Change in immediate packaging of the finished product - Other variation                                                                                                                                           | 11/02/2014 | n/a        |                  |                                                                                                                                                                                                                                                                                   |
| IB/0014   | B.II.b.4.z - Change in the batch size (including batch size ranges) of the finished product - Other variation                                                                                                                  | 31/01/2014 | n/a        |                  |                                                                                                                                                                                                                                                                                   |
| N/0011    | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                               | 17/01/2014 | 05/03/2015 | Labelling and PL | The MAH applied for the introduction of a wrap-around tube label with improved visual images and a multi-strength Package Leaflet with the introduction of colour to differentiate between the strengths for optimum clarity. The labelling and PL have been updated accordingly. |
| IA/0013   | B.II.b.4.a - Change in the batch size (including batch size ranges) of the finished product - Up to 10-fold compared to the originally approved batch size                                                                     | 19/12/2013 | n/a        |                  |                                                                                                                                                                                                                                                                                   |
| IB/0008   | B.II.b.5.b - Change to in-process tests or limits applied during the manufacture of the finished product - Addition of a new test(s) and limits                                                                                | 07/11/2013 | n/a        |                  |                                                                                                                                                                                                                                                                                   |
| IAIN/0010 | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging                                                                                                                                  | 06/11/2013 | n/a        |                  |                                                                                                                                                                                                                                                                                   |

<div style=\"page-break-after: always\"></div>

|             | site                                                                                                                                                                                                                                                                                                                                                                                         |            |     |                       |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------------|
| IAIN/0009   | B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site                                                                                                                                                                                                                                                                                           | 24/10/2013 | n/a |                       |
| IA/0007/G   | This was an application for a group of variations. B.III.1.a.2 - Submission of a new or updated Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer B.III.1.a.2 - Submission of a new or updated Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already | 14/08/2013 | n/a | approved manufacturer |
| IA/0006     | B.III.1.a.2 - Submission of a new or updated Ph. Eur. Certificate of Suitability to the relevant Ph. Eur. Monograph - Updated certificate from an already approved manufacturer                                                                                                                                                                                                              | 17/06/2013 | n/a |                       |
| IAIN/0005/G | This was an application for a group of variations. C.I.9.a - Changes to an existing pharmacovigilance system as described in the DDPS - Change in the QPPV C.I.9.c - Changes to an existing pharmacovigilance system as described in the DDPS - Change of the back-up procedure of the QPPV C.I.9.e - Changes to an existing pharmacovigilance described in the DDPS - Changes in the        | 02/05/2013 | n/a | system as             |

<div style=\"page-break-after: always\"></div>

|             | arrangements with other persons or organisations involved in the fulfilment of pharmacovigilance obligations and described in the DD C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of the pharmacovigilance system                                                                                                                                                                      |            |            |                       | major contractual   |
|-------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|---------------------|
| IAIN/0004/G | This was an application for a group of variations. A.6 - Administrative change - Change in ATC Code/ATC Vet Code B.II.b.2.b.1 - Change to batch release arrangements and quality control testing of the FP - Not including batch control/testing                                                                                                                                                                                                                                                 | 13/12/2012 | 18/12/2013 | SmPC, Annex II and PL |                     |
| IAIN/0003/G | This was an application for a group of variations. C.I.9.e - Changes to an existing pharmacovigilance system as described in the DDPS - Changes in the major contractual arrangements with other persons or organisations involved in the fulfilment of pharmacovigilance obligations and described in the DD C.I.9.h - Changes to an existing pharmacovigilance system as described in the DDPS - Other change(s) to the DDPS that does not impact on the operation of pharmacovigilance system | 22/08/2012 | n/a        |                       | the                 |
| IB/0002     | B.II.b.5.a - Change to in-process tests or limits applied during the manufacture of the finished                                                                                                                                                                                                                                                                                                                                                                                                 | 16/08/2012 | n/a        |                       |                     |

<div style=\"page-break-after: always\"></div>

|         | product - Tightening of in-process limits                                                                                                                                                                                |            |     |
|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| IB/0001 | B.II.e.2.b - Change in the specification parameters and/or limits of the immediate packaging of the finished product - Addition of a new specification parameter to the specification with its corresponding test method | 16/12/2011 | n/a |